Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/9/2008 First Published: 11/29/2007


1.		Phase III Randomized Study of Intrauterine Levonorgestrel and Observation Versus Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				35 to 65				Other				CRUK-POET ISRCTN22037489, EudraCT 2006-001815-30, EU-20784, NCT00566644


2.		A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				40 to 50				Other				4800 CINJ#100401, NCT00161226


3.		Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 18				Other				2008-0094 NCT00788671

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute